glp 1 agonist bone density Study reveals exercise and GLP-1 RA combination preserves health during weight loss Targeting GLP-1, GIP & GCG
Description
Significant Limitations : High costs, access barriers, tolerability issues, and sustainability concerns prevent these agents from achieving their full transformative potential at a population level
This tool evaluates key domains such as Selection, Comparability, and Outcome
Despite important knowledge gaps in our understanding of IR in T1D, targeting IR in overweight/obese patients with T1D may decrease the risk of diabetes complications, contribute to weight loss, and improve glycemic control
Drucker, D
